An NCI-Designated Cancer Center
Everyone knows someone impacted by cancer. One in two men and one in three women will be diagnosed with cancer in their lifetime. Worldwide, cancer rates are expected to increase by as much as 63 percent by 2040.
Current therapies remain insufficient to address the threat. Through innovative biomedical expertise and collaborations, the Salk Cancer Center is working to develop new therapies and cures to enhance the lives of current and future generations.
Salk’s Conquering Cancer Initiative is a scientific and philanthropic initiative to bring together scientists in collaboration to harness new strategies against five deadly cancers: pancreatic, ovarian, lung, brain (glioblastoma) and triple negative breast. Together, Salk researchers will identify cancer’s vulnerabilities and find new methods to attack tumors and leave healthy tissues alone. Our Conquering Cancer Initiative launched in April 2018 and we are pleased to share our Year One Progress report thanks to supporters and collaborators who serve as our valued partners.
We are at a unique and momentous time in cancer research. We invite you to be a part of our Conquering Cancer Initiative.
read more about the
Conquering Cancer Initiative
Sandy Liarakos, CFRE
Senior Director of External Relations
Date: Wednesday, June 24
Time: 12:00 p.m.
Both presentations will be 25 min with room for Q&A afterwards.
Zap70 as a cancer immunotherapeutic target
Speaker: Meredith Frie, Ph.D. (Lillemeier Lab)
Anti-Tumor Immunity in the Context of MHC-I Deficiency
Speaker: Victor Du, Ph.D. (Kaech Lab)
Did you know that Salk Cancer Center has been leading the way in conquering cancer since 1970? Find Out How »